Search results
Innovative silicon-based DNA synthesis from Twist Bioscience, a synthetic biology company. Twist Bioscience makes high-quality gene synthesis, oligo pools, exome, NGS target enrichment, variant libraries and other synthetic DNA tools.
Twist Bioscience developed a proprietary semiconductor-based synthetic DNA manufacturing process featuring a high-throughput silicon platform that allows us to miniaturize the chemistry necessary for DNA synthesis.
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
We are a leading, rapidly growing synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of our platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip.
Twist Bioscience serves Life Science researchers who are changing the world for the better. Coming from diverse fields of medicine, agriculture, industrial chemicals and data storage, scientists...
Find the latest Twist Bioscience Corporation (TWST) stock quote, history, news and other vital information to help you with your stock trading and investing.
Jun 6, 2024 · Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip.
May 13, 2024 · Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip.
Nov 2, 2022 · Twist has been making its way into the biopharma space since 2018 when it promoted Aaron Sato, an expert in antibody-based drugs and machine learning, to lead its biopharma division. Sato has...
Oct 5, 2023 · Berlin, October 5, 2023 – Bayer AG has entered into an antibody discovery, option, and license agreement with Twist Bioscience Corporation, a company offering high-quality synthetic DNA using its silicon platform.
